Search

Search Constraints

You searched for: Author/Creator Lin, Shi‐Ming

Search Results

2. Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial. Issue 5 (29th September 2014)

5. Functional genomics identified a novel protein tyrosine phosphatase receptor type f‐mediated growth inhibition in hepatocarcinogenesis. Issue 6 (25th April 2014)

7. Genome‐wide identification of blood DNA methylation patterns associated with early‐onset hepatocellular carcinoma development in hepatitis B carriers. Issue 2 (10th June 2016)

8. Identification of a liver cirrhosis signature in plasma for predicting hepatocellular carcinoma risk in a population‐based cohort of hepatitis B carriers. Issue 1 (21st August 2012)

9. Increased regulatory T cells in patients with liver cirrhosis correlated with hyperbilirubinemia and predict bacterial complications. Issue 4 (April 2015)

10. Longitudinal change of metabolite profile and its relation to multiple risk factors for the risk of developing hepatitis B‐related hepatocellular carcinoma. Issue 11 (10th September 2020)